Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

Bloomberg BNA Quotes IACP/PCCA on the PEW Charitable Trust Compounding Study

Thursday, March 3, 2016   (0 Comments)
Posted by: Dagmar Anderson
Share |
On February 24, 2016, the Pew Charitable Trust released two reports, indicating discrepancies in how states oversee the practice of compounding medications.


According to Pew, the two reports--National Assessment of State Oversight of Sterile Drug Compounding and Best Practices for State Oversight of Drug Compounding--show enormous variation in state oversight of compounding and look at best practices for patient safety.


In a Bloomberg BNA article outlining the reports, "The key finding of the Pew research is that states vary significantly in their policies for sterile compounding, Elizabeth Jungman, director of public health at the Philadelphia-based Pew, told Bloomberg BNA Feb. 25.


State policies on compounding, such as required quality standards, are generally applicable to all compounding activity, regardless of where it takes place, Jungman said."


IACP/PCCA also are quoted in the Bloomberg BNA story - "In a Feb. 26 joint statement, two Houston-based compounding associations praised Pew's “comprehensive” research. The International Academy of Compounding Pharmacists (IACP), along with the Professional Compounding Centers of America (PCCA), said they supported Pew's recommendation that the United States Pharmacopeial Convention (USP) set standards for compounding practices and strongly recommended that all state Boards of pharmacy adopt all USP standards pertinent to compounding.


“We also agree with the study's theme that state boards should have primary oversight of compounding practices including those in the pharmacy, physician and hospital settings,” the groups said.


IACP and PCCA also said that the issue of office use needs clarification. The groups said they are concerned by the Pew study's “claim that all office-use compounding by 503As [traditional compounding pharmacies] is prohibited by the DQSA.”

According to IACP and PCCA, both Congress and the FDA have voiced support for office use.

"When Congress passed the DQSA, there were six on-the-record congressional statements supporting office use, the IACP and PCCA statement said. The groups said that the support for office use was reiterated by the approved 2016 Congressional appropriations language and by the FDA within its just-released 2017 appropriations justification. Indeed, the two groups said, the FDA has actually stated that office use is needed in some instances."


Bloomberg BNA - Pew Reports Show Wide Variations in State Oversight of Pharmacy Compounding

Please click here to read the entire Bloomberg BNA story.


IACP/PCCA Statement Regarding the Pew Reports


Please click here to read IACP/PCCA's complete statement to Bloomberg BNA regarding the Pew reports.

Association Management Software Powered by YourMembership  ::  Legal